Join to View Full Profile
1415 Old Weisgarber Rd Ste 200Knoxville, TN 37909
Phone+1 865-934-5800
Fax+1 865-934-5801
Dr. Dobbs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 1986 - 1989- University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 1983 - 1986
University of Missouri Kansas City School of MedicineClass of 1983
Certifications & Licensure
TN State Medical License 1989 - 2027
KY State Medical License 1993 - 2026
OK State Medical License 1984 - 1990
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor Start of enrollment: 2007 Dec 01
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsRandomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancerHeinz-Josef Lenz, Philip A. Philip, Mark N. K. Saunders, Tatjana Kolevska, Kalyan Kusum Mukherjee
Cancer Chemotherapy and Pharmacology. 2017-10-17 - 18 citationsA phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carbo...Anshu K. Jain, Randall S. Hughes, Alan B. Sandler, Afshin Dowlati, Lee S. Schwartzberg
Journal of Thoracic Oncology. 2009-06-01 - 17 citationsPhase II Trial of Subcutaneous Interleukin-2, Subcutaneous Interferon-α, Intravenous Combination Chemotherapy, and Oral Tamoxifen in the Treatment of Metastatic Melano...Robert O. Dillman, Gamini Soori, Michael C. Wiemann, Richard S. Schulof, Tracy W. Dobbs
Cancer Biotherapy & Radiopharmaceuticals. 2000-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
